Respiratory disorders
17 results
Applied filters
Doxycycline for sinusitis
18 March 2026SPS PGD template for the supply of doxycycline for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.
Penicillin V (phenoxymethylpenicillin) for sinusitis
18 March 2026SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) where an intranasal steroid is unsuitable or ineffective.
Clarithromycin for sinusitis
18 March 2026SPS PGD template for the supply of clarithromycin for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.
Erythromycin for sinusitis
18 March 2026SPS PGD template for the supply of erythromycin for sinusitis in both penicillin allergy and pregnancy, where an intranasal steroid is unsuitable or ineffective
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
The licence and supporting evidence for omalizumab biosimilar
21 January 2026One omalizumab biosimilar is currently available: Omlyco. Learn about the licensed indications, available preparations, supporting evidence and key differences.
Preparing to use omalizumab biosimilar
20 January 2026One omalizumab biosimilar (Omlyclo) is available and other biosimilars are in development. We offer general information and implementation advice.
Clarithromycin for sore throat
27 January 2025SPS PGD template for the supply of clarithromycin for sore throat in those with a penicillin allergy.
Fluticasone furoate nasal spray for sinusitis
27 January 2025SPS PGD template for the supply of fluticasone furoate nasal spray for sinusitis.
Clarithromycin for otitis media
27 January 2025SPS PGD template for the supply of clarithromycin for otitis media in those with a penicillin allergy.